Lead Exposure and Prevention Advisory Committee (LEPAC), 51033 [2020-18161]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 161 / Wednesday, August 19, 2020 / Notices
https://www.cdc.gov/nchs/about/bsc/
bsc_meetings.htm which was published
in the Federal Register on July 31, 2020,
Volume 85, Number 148, page 46121.
The meeting is being amended to
change the meeting time and should
read as follows:
DATES: The meeting will be held on
September 17, 2020, from 11:00 a.m. to
4:30 p.m., EDT and September 18, 2020,
from 11:00 a.m. to 2:15 p.m., EDT.
The meeting is open to the public.
FOR FURTHER INFORMATION CONTACT:
Sayeedha Uddin, M.D., M.P.H.,
Executive Secretary, NCHS/CDC, Board
of Scientific Counselors, 3311 Toledo
Road, Room 2627, Hyattsville, Maryland
20782, telephone (301) 458–4303, email
SUddin@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–18160 Filed 8–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This
meeting is open to the public by
teleconference but advance registration
by October 16, 2020 is needed to receive
the information to join the meeting. The
registration link is https://
rossstrategic.zoom.us/webinar/register/
WN_QsgX-UlJS02mWW8Kn8SUmg. The
public comment period is scheduled on
October 30, 2020 from 1:30 p.m. until
1:45 p.m. Individuals wishing to make
a comment during the public comment
period, please email your name,
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:34 Aug 18, 2020
Jkt 250001
organization, and phone number by
October 16, 2020 to LEPAC@cdc.gov.
DATES: The meeting will be held on
October 30, 2020, from 9:00 a.m. to 4:30
p.m., EDT.
ADDRESSES: Register in advance at
https://rossstrategic.zoom.us/webinar/
register/WN_QsgXUlJS02mWW8Kn8SUmg to receive
information to join the meeting.
FOR FURTHER INFORMATION CONTACT: Ms.
Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for
Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341,
Telephone: 770–488–3300; email
address pruckart@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Lead Exposure and
Prevention Advisory Committee was
established under Section 2203 of
Public Law 114–322, the Water
Infrastructure Improvements for the
Nation Act; 42 U.S.C. 300j–27, Registry
for Lead Exposure and Advisory
Committee. The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
and Administrator, NCEH/ATSDR, are
authorized under Section 2203 of Public
Law 114–322 (42 U.S.C. 300j–27) to
review research and Federal programs
and services related to lead poisoning
and to identify effective services and
best practices for addressing and
preventing lead exposure in
communities.
The LEPAC is charged with providing
advice and guidance to the Secretary,
HHS, and the Director, CDC and
Administrator, ATSDR, on the: (1)
Review of Federal programs and
services available to individual
communities exposed to lead; (2) review
current research on lead exposure to
identify additional research needs; (3)
review and identify best practices, or
the need for best practices regarding
lead screening and the prevention of
lead poisoning; (4) identify effective
services, including services relating to
healthcare, education, and nutrition for
individuals and communities affected
by lead exposure and lead poisoning,
including in consultation with, as
appropriate, the lead exposure registry
as established in Section 2203(b) of
Public Law 114–322; and (5) undertake
any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda
will include discussions on the 2018
Federal Lead Action Plan; COVID–19
and CDC lead surveillance, lead
laboratory methods; U.S. Housing and
Urban Development’s (HUD) role in lead
poisoning prevention; an update from
CDC’s blood lead reference value
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
51033
workgroup; and a discussion on
effective services and best practices
regarding lead screening and lead
poisoning prevention and research gaps.
Agenda items are subject to change as
priorities dictate. The Director, Strategic
Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for
Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–18161 Filed 8–18–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
[OMB No. 0985–0004]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Title III
Supplemental Form to Financial Status
Report (SF–425)
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The Administration for
Community Living (ACL) is announcing
an opportunity for the public to
comment on the proposed collection of
information listed above. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal agencies are required to
publish a notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
the Proposed Extension without Change
and solicits comments on the
information collection requirements
related to Title III Supplemental Form to
Financial Status Report (SF–425).
DATES: Comments on the collection of
information must be submitted
electronically by 11:59 p.m. (EST) or
postmarked by October 19, 2020.
ADDRESSES: Submit electronic
comments on the collection of
information to: Alice Kelsey. Submit
written comments on the collection of
information to Administration for
SUMMARY:
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 85, Number 161 (Wednesday, August 19, 2020)]
[Notices]
[Page 51033]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-18161]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This meeting is open to the public by
teleconference but advance registration by October 16, 2020 is needed
to receive the information to join the meeting. The registration link
is https://rossstrategic.zoom.us/webinar/register/WN_QsgX-UlJS02mWW8Kn8SUmg. The public comment period is scheduled on October
30, 2020 from 1:30 p.m. until 1:45 p.m. Individuals wishing to make a
comment during the public comment period, please email your name,
organization, and phone number by October 16, 2020 to [email protected].
DATES: The meeting will be held on October 30, 2020, from 9:00 a.m. to
4:30 p.m., EDT.
ADDRESSES: Register in advance at https://rossstrategic.zoom.us/webinar/register/WN_QsgX-UlJS02mWW8Kn8SUmg to receive information to
join the meeting.
FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated
Federal Officer, National Center for Environmental Health, CDC, 4770
Buford Highway, Atlanta, GA 30341, Telephone: 770-488-3300; email
address [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-27,
Registry for Lead Exposure and Advisory Committee. The Secretary,
Department of Health and Human Services (HHS) and by delegation, the
Director, CDC and Administrator, NCEH/ATSDR, are authorized under
Section 2203 of Public Law 114-322 (42 U.S.C. 300j-27) to review
research and Federal programs and services related to lead poisoning
and to identify effective services and best practices for addressing
and preventing lead exposure in communities.
The LEPAC is charged with providing advice and guidance to the
Secretary, HHS, and the Director, CDC and Administrator, ATSDR, on the:
(1) Review of Federal programs and services available to individual
communities exposed to lead; (2) review current research on lead
exposure to identify additional research needs; (3) review and identify
best practices, or the need for best practices regarding lead screening
and the prevention of lead poisoning; (4) identify effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in Section 2203(b) of Public Law 114-
322; and (5) undertake any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include discussions on
the 2018 Federal Lead Action Plan; COVID-19 and CDC lead surveillance,
lead laboratory methods; U.S. Housing and Urban Development's (HUD)
role in lead poisoning prevention; an update from CDC's blood lead
reference value workgroup; and a discussion on effective services and
best practices regarding lead screening and lead poisoning prevention
and research gaps. Agenda items are subject to change as priorities
dictate. The Director, Strategic Business Initiatives Unit, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-18161 Filed 8-18-20; 8:45 am]
BILLING CODE 4163-18-P
